NFE2L2 and early-onset autosomal dominant Alzheimer disease: Additionally, abnormal expression or dysfunction of NFE2L2 has been implicated in the development of various diseases, including cancer, neurodegenerative diseases (such as Alzheimer’s disease and Parkinson’s disease) [21], cardiovascular diseases [22], and inflammatory disorders [23].